Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units
SEC Form 4 Filing
Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of phantom stock units through the company's Supplemental Savings Plan.
Summary
- On September 30, 2024, Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 18 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
- These units are settled in cash following the reporting person's separation from service and may be transferred into an alternative investment account at any time.
- Following the transaction, Bourla directly owns 679,014 shares of Pfizer common stock.
- The price of the common stock was $28.94.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
This is a routine filing related to executive compensation and is typical for publicly traded companies. It provides transparency into the holdings of company insiders.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of transaction: Albert Bourla acquired phantom stock units. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.